All non-traumatic deaths | <800 | A* -R* | All | 29983 | 0.03% (−0.02 to +0.07)16 | 0.06% (0.04–0.08) (lag 0–1)27 | 0.074% (0.062–0.086) (WHO, 1997 estimate)28,29 |
| | | | | | 0.16% (0.043–0.097) (distributed lag 0–40)11 | 0.064% (0.048–0.077)30 |
| | | | | | | 0.05 (0.04–0.06) (combined APHEA and NMMAPS31) |
All respiratory deaths | 460–519 | J* | All | 5878 | 0.11% (0.04–0.20)16 | | |
COPD + asthma deaths | 490–496 | J40*-J47* | ⩾65 | 1441 | 0.25% (0.06–0.46)16 | | |
Circulatory admissions | 390–459 | I* | 0–64 | 9461 | 0.11% (0.04–0.18)17 | 0.05% (0.02–0.08)18 | |
⩾65 | 19410 | 0.05% (−0.00 to +0.10)17 | |
Cardiac admissions | 390–429 | I00–I30 | all ages | 20611 |
0.08% (0.03–0.14)
32
| 0.05% (0.02–0.08)10 | |
>65 | 13870 | | 0.07% (0.04–0.10) 10 | |
IHD admissions | 410–414 | I20–I25 | 0–64 | 4151 | 0.13% (0.03–0.25)17 | | |
⩾65 | 6303 | 0.08% (0.01–0.16)17 | 0.08% (0.03–0.12)10 | |
Respiratory admissions | 460–519 | J* | All | 27345 | 0.08% (0.03–0.16)17 | | 0.08% (0.05 to 0.11) (WHO)28,29 |
| |
0.04% (−0.03 to +0.12)
32
| | |
⩾65 | 12045 |
0.04% (−0.03 to 0.12)
18
| 0.1% (0.04–0.15)18 | |
COPD + asthma admissions | 490–496 | J40–J47 | ⩾65 | 4931 |
0.03 (−0.08 to +0.15)
18
| 0.1% (0.04–0.15)18 | |
Lower respiratory infection admissions | 466, 480–486 | J12–J22 | ⩾65 | 5542 | 0.13% (0.02–0.25)17 | | |
Asthma admissions
|
493
|
J45–J46
|
0–14
| 2251 |
0.06% (−0.08 to +0.2)
18
|
0.12% (0.02–0.23)
18
| |
15–64
| 1955 |
0.14% (−0.01 to +0.3)
18
|
0.11% (0.03–0.18)
18
| |
Asthma attendances at A&E
|
self reported
|
0–14
|
Not available
|
0.30% (0.09–0.50) cumulative
19
| | |
15–64
|
Not available
|
0.24% (0.07–0.42) cumulative
19
| | |